Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.